Can matrix metalloproteinases be targeted in hepatic ischemia/reperfusion injury?
Fowell
Andrew J
AJ
Benyon
R Christopher
RC
D000818:Animals; D050377:Cold Ischemia / Q000009:adverse effects; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008107:Liver Diseases / Q000201:enzymology* / Q000517:prevention & control; D061965:Matrix Metalloproteinase Inhibitors; D020782:Matrix Metalloproteinases / Q000378:metabolism*; D015427:Reperfusion Injury / Q000201:enzymology* / Q000517:prevention & control; D052096:Warm Ischemia / Q000009:adverse effects
D004791:Enzyme Inhibitors; D061965:Matrix Metalloproteinase Inhibitors; D020782:Matrix Metalloproteinases